MRI-ASL evaluation of Ginkgo biloba dropping pills on cerebral blood flow perfusion in patients with CCCI: a randomized, double-blind, parallel controlled study

试验速览

阶段: 4 期
状态: 招募中
发起方: Dongzhimen Hospital of Beijing University of traditional Chinese Medicine

暂无简介。

•(1) The age is between 50 and 70 years old, regardless of gender
•(2) The diagnostic criteria of CCCI were met;
•(3) Cerebral blood flow was 50-70ml / 100g · min, which met the inclusion criteria;
•(4) Those who can meet the test requirements;
•(5) Patients with informed consent and signed informed consent.

•(1) Patients with acute cardiovascular and cerebrovascular diseases;
•(2) Patients with previous history of intracerebral hemorrhage;
•(3) Active ulcer and bleeding tendency, long-term use of anticoagulant drugs (such as warfarin) or taking drugs for promoting blood circulation and removing blood stasis;
•(4) Patients with severe arrhythmia, atrial fibrillation and heart failure;
•(5) Patients with severe primary diseases of heart, liver, kidney, hematopoietic system, endocrine system, respiratory system, liver function 1.5 times higher than the upper limit of normal value, and serum creatinine (CR) higher than normal value;
•(6) Pregnant or lactating women, women with short-term pregnancy plan;
•(7) Allergic constitution;
•(8) Any other life-threatening or serious disease that cannot be treated for 6 weeks, so as to affect the evaluation results;
•(9) Other diseases or mental disorders that the researchers believe may limit the efficacy evaluation or follow-up of patients;
•(10) Patients who have participated in clinical trials of other drugs in the past 4 weeks.

发起方